首页> 外文期刊>European journal of pain : >Associations between autonomic dysfunction and pain in chemotherapy-induced polyneuropathy
【24h】

Associations between autonomic dysfunction and pain in chemotherapy-induced polyneuropathy

机译:化疗引起的多发性神经病中自主神经功能障碍与疼痛之间的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Autonomic neuropathy, a relatively common complication of several chemotherapy agents, can affect the vagus nerve and its pain inhibitory capacity, thus increasing sensitivity to pain. This study aimed to evaluate the relationships between autonomic parasympathetic function and the perception of (1) spontaneous pain; (2) experimental non-painful sensations; and (3) experimental painful sensations in chemotherapy-induced neuropathy patients. Methods: Twenty-seven cancer patients with chemotherapy-induced polyneuropathy were enrolled (20 women, age 56.6 ± 7.9). Autonomic parameters of heart rate variability, deep-breathing and Valsalva ratios, experimental non-painful parameters of warm, cold and mechanical detection thresholds, and painful parameters of heat pain thresholds, pain rating of suprathreshold stimulus, mechanical temporal summation and conditioned pain modulation response were examined. Results: Autonomic parameters and spontaneous pain levels were not associated, yet autonomic parameters were positively correlated with nonpainful sensations - milder autonomic neuropathy was accompanied by milder sensory neuropathy as indicated by several parameters, e.g., lower Valsalva ratio was correlated with higher warmth detection threshold (r = -0.465; p = 0.033). Autonomic parameters were, however, negatively correlated with painful sensations - lower parasympathetic-vagal activity was associated with higher pain sensitivity as indicated by several parameters, e.g., lower Valsalva ratio was correlated with higher pain rating of suprathreshold stimulus (r = -0.559; p = 0.008). Conclusions: Diminished vagal function due to neuropathy is associated with, and may possibly underlie, pain disinhibition expressed as greater levels of experimental pain.
机译:背景:自主神经病是几种化疗药物的一种相对常见的并发症,可影响迷走神经及其疼痛抑制能力,从而增加对疼痛的敏感性。这项研究旨在评估自主神经副交感神经功能与知觉之间的关系。 (2)实验性非疼痛感; (3)化疗引起的神经病患者的实验性疼痛感。方法:招募了27例化疗引起的多发性神经病的癌症患者(20名女性,年龄56.6±7.9岁)。心率变异性,深呼吸和瓦尔瓦尔比的自主性参数,温,冷和机械检测阈值的实验非疼痛参数,热痛阈值的疼痛参数,超阈刺激的疼痛等级,机械时间总和和条件性疼痛调节反应被检查了。结果:自主神经参数和自发性疼痛程度无关,但自主神经参数与无痛感呈正相关-多个参数表明,较轻的自主神经病变伴有较轻的感觉神经病变,例如,较低的Valsalva比与较高的温暖检测阈值相关( r = -0.465; p = 0.033)。然而,自主神经参数与疼痛感呈负相关-如数个参数所示,副交感神经迷走神经活动降低与较高的疼痛敏感性相关,例如,较低的Valsalva比与阈上刺激的较高疼痛评级相关(r = -0.559; p = 0.008)。结论:由于神经病引起的迷走神经功能减弱与疼痛抑制作用有关,并可能是由于实验性疼痛水平升高所致的疼痛抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号